Market Cap

Organon & Co. Market Capitalization:

$7.32 Billion

USD as of Jan. 1, 2023

business Organon & Co. Company Profile

Organon & Co. Main Stock Listing

show_chart NYSE: OGN

Market Capitalization History of Organon & Co.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Johnson & Johnson $461.85 B
Lilly $347.61 B
Pfizer $287.63 B
AbbVie $285.80 B
Merck $281.30 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $495.37 B
Johnson & Johnson $461.85 B
Lilly $347.61 B
Novo Nordisk $304.61 B
Pfizer $287.63 B

Yearly evolution of Organon & Co. market cap

Date Market Cap YoY Change
Jan. 1, 2023 $7.32 B -8.48%
Jan. 1, 2022 $8.00 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Organon & Co. Categories

United States languages Healthcare languages Drug Manufacturers—General
United States Healthcare United States Drug Manufacturers—General

Stocks & Indices

Organon & Co. has the following listings and related stock indices.


Stock: NYSE: OGN

Stock: FSX: 7XP

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.